Advance Search | Bentham Science

The Emerging Role of NRAS Mutations in Colorectal Cancer Patients Selected for Anti-EGFR Therapies

Journal: Reviews on Recent Clinical Trials
Volume: 9 Issue: 1 Year: 2014 Page: 8-12
Author(s): Fausto Meriggi,William Vermi,Paola Bertocchi,Alberto Zaniboni

Combining Anti-Epidermal Growth Factor Receptor (EGFR) and Anti-Angiogenic Strategies in Advanced NSCLC: We Should have Known Better...

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3901-3913
Author(s): Massimo Di Maio,Alessandro Morabito,Maria Carmela Piccirillo,Gennaro Daniele,Pasqualina Giordano,Raffaele Costanzo,Claudia Sandomenico,Agnese Montanino,Gaetano Rocco,Francesco Perrone

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

Journal: Current Drug Targets
Volume: 15 Issue: 13 Year: 2014 Page: 1225-1230
Author(s): Riccardo Giampieri,Giuseppe Aprile,Michela Del Prete,Luca Faloppi,Maristella Bianconi,Marta Bonotto,Giampiero Fasola,Stefano Cascinu,Mario Scartozzi

The Role of cMet in Non-Small Cell Lung Cancer Resistant to EGFRInhibitors: Did We Really Find the Target?

Journal: Current Drug Targets
Volume: 15 Issue: 14 Year: 2014 Page: 1284-1292
Author(s): Francesco Passiglia,Nele Van Der Steen,Luis Raez,Patrick Pauwels,Ignacio Gil-Bazo,Edgardo Santos,Daniele Santini,Giovanni Tesoriere,Antonio Russo,Giuseppe Bronte,Karen Zwaenepoel,Federico Cappuzzo,Christian Rolfo

Structural Elucidation of Unique Inhibitory Activities of Two Thiazolo[ 4,5-d]pyrimidines Against Epidermal Growth Factor Receptor (EGFR): Implications for Successful Drug Design

Journal: Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2014 Page: 46-58
Author(s): Petar M. Mitrasinovic

Research Article

Inhibitory Activity Against Epidermal Growth Factor Receptor (EGFR) Based on Single Point Mutations of Active Site Residues

Journal: Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2014 Page: 252-270
Author(s): Petar M. Mitrasinovic

Anti-Angiogenic Drugs and Biomarkers in Non-Small-Cell Lung Cancer: 'A Hard Days Night'

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3958-3972
Author(s): Sara Pilotto,Maria Bonomi,Francesco Massari,Michele Milella,Ludovica Ciuffreda,Matteo Brunelli,Matteo Fassan,Marco Chilosi,Aldo Scarpa,Giampaolo Tortora,Emilio Bria

Pharmacogenetics of Non-small Cell Lung Cancer (NSCLC): Time to Work it Out?

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3863-3874
Author(s): Elena Galvani,Francesca Toffalorio,Godefridus J. Peters,Tommaso De Pas,Elisa Giovannetti

Cetuximab Inhibits Gastric Cancer Growth in vivo, Independent of KRAS Status

Journal: Current Cancer Drug Targets
Volume: 14 Issue: 2 Year: 2014 Page: 217-224
Author(s): Min Shi,Hailong Shi,Jun Ji,Qu Cai,Xuehua Chen,Yingyan Yu,Bingya Liu,Zhenggang Zhu,Jun Zhang

Targeted Therapies in Hepatocellular Carcinoma

Journal: Current Medicinal Chemistry
Volume: 21 Issue: 8 Year: 2014 Page: 966-974
Author(s): F. Bronte, G. Bronte, S. Cusenza, E. Fiorentino, C. Rolfo, G. Cicero, E. Bronte, V. Di Marco, A. Firenze, G. Angarano, T. Fontana, A. Russo

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "anti-EGFR"